Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

WDR73-related galloway mowat syndrome with collapsing glomerulopathy.

El Younsi M, Kraoua L, Meddeb R, Ferjani M, Trabelsi M, Ouertani I, Maazoul F, Abid N, Gargah T, M'rad R.

Eur J Med Genet. 2019 Sep;62(9):103550. doi: 10.1016/j.ejmg.2018.10.002. Epub 2018 Oct 10.

PMID:
30315938
2.

Robust analysis of the determinants of healthcare expenditure growth: evidence from panel data for low-, middle- and high-income countries.

Younsi M, Chakroun M, Nafla A.

Int J Health Plann Manage. 2016 Oct;31(4):580-601. doi: 10.1002/hpm.2358. Epub 2016 May 3.

PMID:
27139801
3.

Health-Related Quality-of-Life Measures: Evidence from Tunisian Population Using the SF-12 Health Survey.

Younsi M.

Value Health Reg Issues. 2015 Sep;7:54-66. doi: 10.1016/j.vhri.2015.07.004. Epub 2015 Nov 14.

PMID:
29698153
4.

Regulation of SREBPs by Sphingomyelin in Adipocytes via a Caveolin and Ras-ERK-MAPK-CREB Signaling Pathway.

Makdissy N, Haddad K, Mouawad C, Popa I, Younsi M, Valet P, Brunaud L, Ziegler O, Quilliot D.

PLoS One. 2015 Jul 31;10(7):e0133181. doi: 10.1371/journal.pone.0133181. eCollection 2015.

5.

Severe aortic regurgitation after device closure of patent ductus arteriosus: an unexpected killjoy.

Baruteau AE, Younsi MS.

World J Pediatr Congenit Heart Surg. 2015 Apr;6(2):346-7. doi: 10.1177/2150135115574009. No abstract available.

PMID:
25870365
6.

Measuring health-related quality of life: psychometric evaluation of the Tunisian version of the SF-12 health survey.

Younsi M, Chakroun M.

Qual Life Res. 2014 Sep;23(7):2047-54. doi: 10.1007/s11136-014-0641-8. Epub 2014 Feb 11.

PMID:
24515673
7.

[Emergence of glycopeptide resistant Enterococcus faecium in Algeria: a case report].

Hamidi M, Ammari H, Ghaffor M, Benamrouche N, Tali-Maamar H, Tala-Khir F, Younsi M, Rahal K.

Ann Biol Clin (Paris). 2013 Jan-Feb;71(1):104-6. doi: 10.1684/abc.2012.0781. French.

8.

Functional differences in Leuconostoc sensitive and resistant strains to mesenterocin 52A, a class IIa bacteriocin.

Jasniewski J, Cailliez-Grimal C, Younsi M, Millière JB, Revol-Junelles AM.

FEMS Microbiol Lett. 2008 Dec;289(2):193-201. doi: 10.1111/j.1574-6968.2008.01381.x.

9.

Fluorescence anisotropy analysis of the mechanism of action of mesenterocin 52A: speculations on antimicrobial mechanism.

Jasniewski J, Cailliez-Grimal C, Younsi M, Millière JB, Revol-Junelles AM.

Appl Microbiol Biotechnol. 2008 Nov;81(2):339-47. doi: 10.1007/s00253-008-1677-x. Epub 2008 Sep 11.

PMID:
18784922
10.

Sphingomyelin/cholesterol ratio: an important determinant of glucose transport mediated by GLUT-1 in 3T3-L1 preadipocytes.

Al-Makdissy N, Younsi M, Pierre S, Ziegler O, Donner M.

Cell Signal. 2003 Nov;15(11):1019-30.

PMID:
14499345
11.

Erythrocyte membrane phospholipid composition is related to hyperinsulinemia in obese nondiabetic women: effects of weight loss.

Younsi M, Quilliot D, Al-Makdissy N, Delbachian I, Drouin P, Donner M, Ziegler O.

Metabolism. 2002 Oct;51(10):1261-8.

PMID:
12370844
12.

Urinary excretion of free cysteine in critically ill neonates.

Cambonie G, Bellet H, Houdon L, Vallat C, El Younsi M, Vergnes C.

Acta Paediatr. 2001 Dec;90(12):1405-10.

PMID:
11853338
13.

Down-regulation of peroxisome proliferator-activated receptor-gamma gene expression by sphingomyelins.

Al-Makdissy N, Bianchi A, Younsi M, Picard E, Valet P, Martinet N, Dauça M, Donner M.

FEBS Lett. 2001 Mar 30;493(2-3):75-9.

14.

Adipocyte and erythrocyte plasma membrane phospholipid composition and hyperinsulinemia: a study in nondiabetic and diabetic obese women.

Zeghari N, Younsi M, Meyer L, Donner M, Drouin P, Ziegler O.

Int J Obes Relat Metab Disord. 2000 Dec;24(12):1600-7.

PMID:
11126212
15.

Adipocyte membrane phospholipids and PPAR-gamma expression in obese women: relationship to hyperinsulinemia.

Zeghari N, Vidal H, Younsi M, Ziegler O, Drouin P, Donner M.

Am J Physiol Endocrinol Metab. 2000 Oct;279(4):E736-43.

16.

Amphotericin B resistance and membrane fluidity in Kluyveromyces lactis strains.

Younsi M, Ramanandraibe E, Bonaly R, Donner M, Coulon J.

Antimicrob Agents Chemother. 2000 Jul;44(7):1911-6.

17.

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections.

Mathurin P, Thibault V, Kadidja K, Ganne-Carrié N, Moussalli J, El Younsi M, Di Martino V, Lunel F, Charlotte F, Vidaud M, Opolon P, Poynard T.

J Viral Hepat. 2000 Jan;7(1):15-22.

PMID:
10718938
18.

Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting.

Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, Boudet MJ, Hay JM, Erlinger S, Benhamou JP, Belghiti J, Valla D.

Hepatology. 1999 Jul;30(1):84-9.

PMID:
10385643
19.

Implication of cell wall constituents in the sensitivity of Kluyveromyces lactis strains to amphotericin B.

Ramanandraibe E, Younsi M, Coulon J, Loppinet V, Hakkou A, Bonaly R.

Res Microbiol. 1998 Feb;149(2):109-18.

PMID:
9766214
20.

Hepatic venous outflow block caused by short-length hepatic vein stenoses.

Valla D, Hadengue A, el Younsi M, Azar N, Zeitoun G, Boudet MJ, Molas G, Belghiti J, Erlinger S, Hay JM, Benhamou JP.

Hepatology. 1997 Apr;25(4):814-9.

PMID:
9096581
21.

Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.

Cadranel JF, el Younsi M, Pidoux B, Zylberberg P, Benhamou Y, Valla D, Opolon P.

Eur J Gastroenterol Hepatol. 1995 Apr;7(4):325-9.

PMID:
7600138

Supplemental Content

Loading ...
Support Center